Clinical Trial Update: Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders [Phase 1]

View source ↗

Summary

NEI-sponsored Phase 1 trial evaluated intravitreal injections of Triamcinolone Acetonide for age-related macular degeneration and retinal vein occlusion; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Retinal Vein Occlusion

Drugs mentioned

• TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Macular Degeneration, Retinal Vein Occlusion | Phase 1 | Status: COMPLETED